Bora Emre, Velakoulis Dennis, Walterfang Mark
Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Carlton South, Victoria 3053, Australia.
Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Carlton South, Victoria 3053, Australia.
Behav Brain Res. 2016 Jan 15;297:131-40. doi: 10.1016/j.bbr.2015.10.001. Epub 2015 Oct 8.
Neurocognitive impairment in Huntington's disease (HD) frequently includes deficits in emotion recognition, and recent studies have also provided evidence for deficits in theory of mind (ToM). There have been conflicting reports regarding the extent of emotion recognition and ToM deficits before the onset of motor symptoms in HD. In this meta-analysis, ToM and emotion recognition performances of 2226HD or pre-manifest HD and 998 healthy controls were included in the meta-analysis. Meta-regression analyses were conducted to investigate the relationship between social cognition deficits and demographic, cognitive and clinical features in HD. HD patients were significantly less accurate than controls in ToM and across all emotions in response to both facial and vocal stimuli. ToM (d=1.72) and recognition of negative emotions (d=1.20-1.33), especially anger, disgust and fear (d=1.26-1.52) were severely impaired. Pre-manifest HD was also associated with impairment in social cognition. The severity of emotion recognition impairment was significantly associated with disease burden, proximity of onset of motor symptoms and cognitive impairment. Social cognition impairments are potential biomarkers of disease onset and progression in HD.
亨廷顿舞蹈症(HD)中的神经认知障碍常常包括情绪识别缺陷,并且最近的研究也为心理理论(ToM)缺陷提供了证据。关于HD运动症状出现之前情绪识别和ToM缺陷的程度,一直存在相互矛盾的报告。在这项荟萃分析中,纳入了2226名HD患者或症状前HD患者以及998名健康对照者的ToM和情绪识别表现进行荟萃分析。进行了元回归分析,以研究HD患者社会认知缺陷与人口统计学、认知和临床特征之间的关系。HD患者在ToM方面以及对面部和声音刺激的所有情绪反应方面,准确性均显著低于对照组。ToM(d=1.72)以及对负面情绪的识别(d=1.20 - 1.33),尤其是愤怒、厌恶和恐惧(d=1.26 - 1.52)严重受损。症状前HD也与社会认知障碍有关。情绪识别障碍的严重程度与疾病负担、运动症状发作的临近程度以及认知障碍显著相关。社会认知障碍是HD疾病发作和进展的潜在生物标志物。